Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-15

FDA Approved: LEVETIRACETAM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approves a supplemental application for levetiracetam from Amneal Pharmaceuticals LLC, authorizing generic production and distribution of the drug. This…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)